EODData

MEMBERSHIP REGISTER LOG IN

FRA, 6IB: Innovent Biologics Inc

20 Nov 2025
LAST:

9.950

CHANGE:
 0.20		OPEN:
9.950		HIGH:
9.950		ASK:
0.000		VOLUME:
6.0K
CHG(%):
2.05		PREV:
9.750		LOW:
9.950		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Nov 259.9509.9509.9509.9506.0K
19 Nov 259.8009.8009.7509.7506.0K
18 Nov 259.8509.9009.8509.9006.0K
17 Nov 259.9509.9509.9009.9506.0K
13 Nov 2510.10010.10010.10010.1006.0K
12 Nov 259.55010.0009.5509.8506.0K
11 Nov 259.4009.4009.3009.300239
06 Nov 259.7009.7509.7009.750239
04 Nov 259.5009.6509.5009.650239
03 Nov 259.95010.0009.95010.000239

PROFILE

Name:Innovent Biologics Inc
About:Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverematinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), Dupert (fulzerasib), DOVBLERON (taletrectinib), Jaypirca (pirtobrutinib), limertinib, and SYCUME (teprotumumab N01 injection). The company is also developing three new drugs, which are under regulatory review; four assets in Phase 3 and pivotal clinical trials; and 15 molecules in early clinical stage. In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.
Sector:Healthcare
Industry:Biotechnology
Address:168 Dongping Street, Suzhou, China, 215123
Website:https://www.innoventbio.com
ISIN:KYG4818G1010
LEI:25490058ONL9SCIE1R22

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:125.00 
Forward P/E:93.46 
Price to Sales:1.50 
Price to Book:1.15 
Profit Margin:0.10 
Operating Margin:0.13 
Return on Assets:0.03 
Return on Equity:0.08 
Revenue:1.392B 
EBITDA:30.8M 
Shares:1.709B 
Market Cap:17.009B 

TECHNICAL INDICATORS

MA5:9.930.2%
MA10:9.821.3%
MA20:9.623.4%
MA50:10.081.3%
MA100:9.990.4%
MA200:7.9225.6%
STO9:81.25 
STO14:83.33 
RSI14:53.49
WPR14:-16.67 
MTM14:0.70
ROC14:0.08 
ATR:0.38 
Week High:10.101.5%
Week Low:9.752.1%
Month High:10.101.5%
Month Low:9.0025.6%
Year High:11.7017.6%
Year Low:3.62174.6%
Volatility:39.12